171 related articles for article (PubMed ID: 31292394)
1. Successful Control of Dasatinib-related Chylothorax by the Japanese Herbal Medicine "Goreisan".
Sasaki H; Kimizuka Y; Ogata H; Okada Y; Ota S; Sano T; Watanabe C; Maki Y; Yamamoto T; Tagami Y; Miyata J; Hayashi N; Fujikura Y; Kawana A
Intern Med; 2019 Nov; 58(21):3139-3141. PubMed ID: 31292394
[TBL] [Abstract][Full Text] [Related]
2. Dasatinib-induced chylothorax: report of a case and review of the literature.
Chen B; Wu Z; Wang Q; Li W; Cheng D
Invest New Drugs; 2020 Oct; 38(5):1627-1632. PubMed ID: 32248338
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib-induced Chylothorax in Chronic Myeloid Leukemia.
Alqattan Y; Ali S; Almohammad R; Kayali N; Alhuraiji A
Gulf J Oncolog; 2022 Sep; 1(40):74-77. PubMed ID: 36448074
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature.
Hickman K; Diaz E; Graham R; Adams R; Ngwube A
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e665-e667. PubMed ID: 31688632
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced chylothorax as a rare pleural complication in dasatinib therapy for chronic myeloid leukaemia.
Ng IK; Ruparel M; Chan EH; Khoo KL
J R Coll Physicians Edinb; 2024 Mar; 54(1):44-47. PubMed ID: 38486345
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Pitfalls of Chylothorax After Dasatinib Treatment of Chronic Myeloid Leukemia.
Kelly RL; Bae JY; D'Annunzio S; Montanari F
Am J Case Rep; 2022 Nov; 23():e938319. PubMed ID: 36444127
[TBL] [Abstract][Full Text] [Related]
7. [Chylothorax Related with Dasatinib in the Treatment of Chronic Myeloid Leukemia: Report of 3 Cases].
Yang L; Lu N; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1348-1353. PubMed ID: 27784355
[TBL] [Abstract][Full Text] [Related]
8. Chylothorax: complication attributed to dasatinib use.
Al-Abcha A; Iftikhar MH; Abu Rous F; Laird-Fick H
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31848139
[TBL] [Abstract][Full Text] [Related]
9. Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management.
Cortes JE; Jimenez CA; Mauro MJ; Geyer A; Pinilla-Ibarz J; Smith BD
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):78-82. PubMed ID: 28082112
[TBL] [Abstract][Full Text] [Related]
10. Nodular histiocytic hyperplasia: Is this a cause of dasatinib-pleural effusion?
Hamada S; Hayashi E; Tsukino M
Arch Bronconeumol; 2017 Apr; 53(4):212-213. PubMed ID: 27825730
[No Abstract] [Full Text] [Related]
11. Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.
Schiffer CA; Cortes JE; Hochhaus A; Saglio G; le Coutre P; Porkka K; Mustjoki S; Mohamed H; Shah NP
Cancer; 2016 May; 122(9):1398-407. PubMed ID: 26998677
[TBL] [Abstract][Full Text] [Related]
12. Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
Hagihara M; Iriyama N; Yoshida C; Wakita H; Chiba S; Okamoto S; Kawakami K; Takezako N; Kumagai T; Inokuchi K; Ohyashiki K; Taguchi J; Yano S; Igarashi T; Kouzai Y; Morita S; Sakamoto J; Sakamaki H
Oncol Rep; 2016 Nov; 36(5):2976-2982. PubMed ID: 27665844
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of tolvaptan in treating dasatinib-induced pleural effusions in patients with chronic myelogenous leukemia.
Aoyama R; Ishikawa J; Harada K
J Cardiol; 2020 Feb; 75(2):203-207. PubMed ID: 31416783
[TBL] [Abstract][Full Text] [Related]
14. A 68-Year-Old Man With Chronic Myelogenous Leukemia and a Large Unilateral Pleural Effusion.
Alter A; Chaisson N; Mukherjee S; Gildea T
Chest; 2018 Feb; 153(2):e33-e36. PubMed ID: 29406237
[TBL] [Abstract][Full Text] [Related]
15. Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure.
Quintás-Cardama A; Kantarjian H; O'brien S; Borthakur G; Bruzzi J; Munden R; Cortes J
J Clin Oncol; 2007 Sep; 25(25):3908-14. PubMed ID: 17761974
[TBL] [Abstract][Full Text] [Related]
16. Intercostal Herniation of Pleural Fluid.
Newman TA; Brady AK; Shriki JE; Takasugi JE; Adamson R
Am J Respir Crit Care Med; 2020 Jan; 201(2):e5. PubMed ID: 31433948
[No Abstract] [Full Text] [Related]
17. [A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib].
Sato M; Watanabe S; Aoki N; Asakawa K; Moriyama H; Oshima Y; Koya T; Okazuka K; Kikuchi T
Gan To Kagaku Ryoho; 2018 May; 45(5):851-854. PubMed ID: 30026450
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib-associated chylothorax in a pediatric patient with chronic myeloid leukemia: a case report and literature review.
Liu Q; Fu J; Zhang A
Transl Cancer Res; 2023 Jan; 12(1):194-200. PubMed ID: 36760377
[TBL] [Abstract][Full Text] [Related]
19. Chylothorax Secondary to Dasatinib.
Molina V; Vañes S; Castelló C; Chiner E
Arch Bronconeumol (Engl Ed); 2020 Sep; 56(9):599-601. PubMed ID: 32493642
[No Abstract] [Full Text] [Related]
20. [Reversible dasatinib-related pulmonary arterial hypertension in a CML patient].
Nagasaki J; Aoyama Y; Nomoto Y; Ido K; Ichihara H; Mugitani A
Rinsho Ketsueki; 2016 May; 57(5):618-23. PubMed ID: 27263788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
